Postmarketing clinical study on AO-128

Status

Unknown

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1080220971

Enrollment

197

Registered

2010-01-21

Start date

2010-01-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose tolerance

Interventions

investigational material(s) Generic name etc : AO-128 (BASEN Tablets 0.2) INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investiga

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.The subject is an out patient during screening 2.The subject signs a written informed consent form prior to the initiation of any study procedures. And the others.

Exclusion criteria

Exclusion criteria: 1.The subject with serious cardiac disease, cerebrovascular disorder, or any serious pancreatic or hematological disease, etc.. 2.The subject who is considered ineligible to participate in the study by the investigator or subinvestigator. And the others.

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026